SCHEMBL3825804

SCHEMBL3825804

CC(C)C(=O)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.69
HSD17B10 Q99714 2/20 0.69
ALDH1A1 P00352 2/20 0.57
RAB9A P51151 1/20 0.57
SERPINE1 P05121 6/20 0.56
AKR1C4 P17516 1/20 0.54
AKR1C3 P42330 1/20 0.54
AKR1C2 P52895 1/20 0.54
AKR1C1 Q04828 1/20 0.54
PPARG P37231 1/20 0.52
PPARA Q07869 1/20 0.52
GAA P10253 1/20 0.52
TRPM4 Q8TD43 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13823615 0.88 KDM4E (0.65) KDM4EHSD17B10ALDH1A1RAB9ASERPINE1
SCHEMBL13724738 0.84 KDM4E (0.65) KDM4EHSD17B10ALDH1A1RAB9ASERPINE1
SCHEMBL3708748 0.84 KDM4E (0.58) KDM4EHSD17B10ALDH1A1RAB9AGAA
SCHEMBL27519937 0.82 KDM4E (0.59) KDM4EHSD17B10ALDH1A1RAB9ASERPINE1
SCHEMBL14254797 0.81 ALDH1A1 (0.55) ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7045036 0.81 KDM4E (1.00) KDM4EHSD17B10ALDH1A1SERPINE1AKR1C4
SCHEMBL419300 0.81 KDM4E (0.60) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3
SCHEMBL1016189 0.81 KDM4E (0.74) KDM4EHSD17B10ALDH1A1SERPINE1AKR1C4
SCHEMBL14383904 0.81 GAA (0.45) KDM4EHSD17B10ALDH1A1RAB9AGAA
SCHEMBL20063107 0.81 KDM4E (0.57) KDM4EHSD17B10ALDH1A1RAB9ASERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 US disclosed
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 US disclosed
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 US disclosed
EP-1646615-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2009-08-26 EP disclosed
EP-1646615-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2009-08-26 EP disclosed
EP-1646615-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2006-04-19 EP disclosed
US-20050059687-A1 Modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-03-17 US disclosed
WO-2004111014-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059687-A1 Modulators of ATP-Binding Cassette transporters CFTR, ABCB1, ABCC2 KDM4E 4337/4885HSD17B10 1526/4885ALDH1A1 1892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.